News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG) (JOBS) Investors Struggle with Confusing Data


12/9/2009 7:07:57 AM

Bookmark and Share

Reuters -- Celgene Corp (CELG.O) investors were struggling on Tuesday to sort through confusing results from a key trial of the company's cancer drug Revlimid.

Read at Reuters


comments powered by Disqus
Reuters
Celgene
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES